English

Bio-Matrix Scientific Group, Inc.

EDGAR

Annual report (10-K) · filed 2022-05-13

113 filing records in this dataset, filed from 2001-04-18 to 2022-05-13. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

61.1 thousand USD

2021 Q4 · USD

Exact inputs and evidence

Revenue: 64074 USD Source
Revenue: 3000 USD Source

Operating margin

-1,006.9%

2021 Q4 · %

Exact inputs and evidence

Operating Income: -2227752 USD Source
Operating Income: -1612800 USD Source
Revenue: 64074 USD Source
Revenue: 3000 USD Source

Operating cash flow

-143 thousand USD

2021 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -1320626 USD Source
Operating Cash Flow: -1177541 USD Source

Free cash flow

-164 thousand USD

2021 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -1320626 USD Source
Operating Cash Flow: -1177541 USD Source
Capital Expenditure: 33661 USD Source
Capital Expenditure: 13000 USD Source

Cash and cash equivalents: 32.5 thousand USD 2021-07-31 Source
Exact value

32473 USD
Long-term debt including current maturities: 2.5 thousand USD 2015-06-30 Source
Exact value

2500 USD
Shares outstanding: 136 million shares 2021-07-31 Source
Exact value

136070171 shares

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-1.85 million USD

2020-08-01 – 2021-07-31

Exact inputs and evidence

Net income: -477730 USD · 2020-08-01 – 2020-10-31 Source
Net income: -522673 USD · 2020-11-01 – 2021-01-31 Source
Net income: 84266 USD · 2021-02-01 – 2021-04-30 Source
Net income: -1851108 USD · 2020-08-01 – 2021-07-31 Source
Net income: -916137 USD · 2020-08-01 – 2021-04-30 Source

Operating cash flow

-1.32 million USD

2020-08-01 – 2021-07-31

Exact inputs and evidence

Operating cash flow: -492742 USD · 2020-08-01 – 2020-10-31 Source
Operating cash flow: -773916 USD · 2020-08-01 – 2021-01-31 Source
Operating cash flow: -492742 USD · 2020-08-01 – 2020-10-31 Source
Operating cash flow: -1177541 USD · 2020-08-01 – 2021-04-30 Source
Operating cash flow: -773916 USD · 2020-08-01 – 2021-01-31 Source
Operating cash flow: -1320626 USD · 2020-08-01 – 2021-07-31 Source
Operating cash flow: -1177541 USD · 2020-08-01 – 2021-04-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2022-05-13.

Financial data available through: 2021-07-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2021-07-31
Operating income: 7 of 11 periods available· newest 2021-07-31
Net income: 6 of 11 periods available· newest 2021-07-31
Operating cash flow: 3 of 11 periods available· newest 2021-07-31
Capital expenditure: 1 of 11 periods available· newest 2021-07-31
Total assets: 6 of 11 periods available· newest 2021-07-31
Total liabilities: 6 of 11 periods available· newest 2021-07-31
Current assets: 6 of 11 periods available· newest 2021-07-31
Current liabilities: 6 of 11 periods available· newest 2021-07-31
Cash and cash equivalents: 6 of 11 periods available· newest 2021-07-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2014-09-30
Shares outstanding: 6 of 11 periods available· newest 2021-07-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

No unambiguous prior-year comparison is available for the latest reporting period.

Comparable inputs unavailable for: Revenue, Net income, Operating cash flow, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2021 2020-08-01 – 2021-07-31

Revenue USD 64,074 100% of revenue
Operating costs Derived USD 2.29 million 3,577% of revenue
Operating income −USD 2.23 million −3,477% of revenue
Tax, interest and other Derived −USD 376,644 −588% of revenue
Net income −USD 1.85 million −2,889% of revenue

Cash

Operating cash flow −USD 1.32 million −2,061% of revenue
Capital expenditure USD 33,661 53% of revenue
Free cash flow Derived −USD 1.35 million −2,114% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2012 Not shown: operating income or net income is not reported.
2013 Not shown: operating income or net income is not reported.
2014 Not shown: operating income or net income is not reported.
2015 Operating loss: operating costs were 1,228% of revenue.
2016 Not shown: operating income or net income is not reported.
2021 Operating loss: operating costs were 3,577% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2012 2011-10-01 – 2012-09-30	0	795426 Derived	-795426	957383 Derived	-1752809	Unavailable	Source 2011-10-01 – 2012-09-30: 0 USD Inspect Revenue Open source 2011-10-01 – 2012-09-30: -795426 USD Inspect Operating Income Open source 2011-10-01 – 2012-09-30: -1752809 USD Inspect Net Income Open source
2013 2012-10-01 – 2013-09-30	0	1527911 Derived	-1527911	477086 Derived	-2004997	Unavailable	Source 2012-10-01 – 2013-09-30: 0 USD Inspect Revenue Open source 2012-10-01 – 2013-09-30: -1527911 USD Inspect Operating Income Open source 2012-10-01 – 2013-09-30: -2004997 USD Inspect Net Income Open source
2014 2013-10-01 – 2014-09-30	0	869315 Derived	-869315	1211643 Derived	-2080958	Unavailable	Source 2013-10-01 – 2014-09-30: 0 USD Inspect Revenue Open source 2013-10-01 – 2014-09-30: -869315 USD Inspect Operating Income Open source 2013-10-01 – 2014-09-30: -2080958 USD Inspect Net Income Open source
2015 2014-10-01 – 2015-09-30	192000	2358389 Derived	-2166389	51923930 Derived	-54090319	Unavailable	Source 2014-10-01 – 2015-09-30: 192000 USD Inspect Revenue Open source 2014-10-01 – 2015-09-30: -2166389 USD Inspect Operating Income Open source 2014-10-01 – 2015-09-30: -54090319 USD Inspect Net Income Open source
2016 2015-10-01 – 2016-09-30	100000	3226163 Derived	-3126163	Unavailable	Unavailable	Unavailable	Source 2015-10-01 – 2016-09-30: 100000 USD Inspect Revenue Open source 2015-10-01 – 2016-09-30: -3126163 USD Inspect Operating Income Open source 2015-10-01 – 2016-09-30: -1730493 USD Inspect Operating Cash Flow Open source
2021 2020-08-01 – 2021-07-31	64074	2291826 Derived	-2227752	-376644 Derived	-1851108	-1354287 Derived	Source 2020-08-01 – 2021-07-31: 64074 USD Inspect Revenue Open source 2020-08-01 – 2021-07-31: -2227752 USD Inspect Operating Income Open source 2020-08-01 – 2021-07-31: -1851108 USD Inspect Net Income Open source 2020-08-01 – 2021-07-31: -1320626 USD Inspect Operating Cash Flow Open source 2020-08-01 – 2021-07-31: 33661 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 64.1K 2021

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20122012-09-30	Revenue	0	Revenue: 0 Open source
20132013-09-30	Revenue	0	Revenue: 0 Open source
20142014-09-30	Revenue	0	Revenue: 0 Open source
20152015-09-30	Revenue	192000	Revenue: 192000 Open source
20162016-09-30	Revenue	100000	Revenue: 100000 Open source
20212021-07-31	Revenue	64074	Revenue: 64074 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-47.9% 2016

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20122012-09-30	Year over year	No prior comparable period	Revenue: 0 Open source
20132013-09-30	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20142014-09-30	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20152015-09-30	Year over year	No prior comparable period	Revenue: 192000 Open source Revenue: 0 Open source
20162016-09-30	Year over year	-47.9%	Revenue: 100000 Open source Revenue: 192000 Open source
20212021-07-31	Year over year	No prior comparable period	Revenue: 64074 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -3,476.8% 2021

Net margin -2,889% 2021

Free cash flow margin -2,113.6% 2021

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20122012-09-30	Operating margin	Not reported	Operating Income: -795426 Open source Revenue: 0 Open source
20132013-09-30	Operating margin	Not reported	Operating Income: -1527911 Open source Revenue: 0 Open source
20142014-09-30	Operating margin	Not reported	Operating Income: -869315 Open source Revenue: 0 Open source
20152015-09-30	Operating margin	-1,128.3%	Operating Income: -2166389 Open source Revenue: 192000 Open source
20162016-09-30	Operating margin	-3,126.2%	Operating Income: -3126163 Open source Revenue: 100000 Open source
20212021-07-31	Operating margin	-3,476.8%	Operating Income: -2227752 Open source Revenue: 64074 Open source
20122012-09-30	Net margin	Not reported	Net Income: -1752809 Open source Revenue: 0 Open source
20132013-09-30	Net margin	Not reported	Net Income: -2004997 Open source Revenue: 0 Open source
20142014-09-30	Net margin	Not reported	Net Income: -2080958 Open source Revenue: 0 Open source
20152015-09-30	Net margin	-28,172%	Net Income: -54090319 Open source Revenue: 192000 Open source
2016-09-30	Net margin	Not reported	Revenue: 100000 Open source
20212021-07-31	Net margin	-2,889%	Net Income: -1851108 Open source Revenue: 64074 Open source
20122012-09-30	Free cash flow margin	Not reported	Revenue: 0 Open source
20132013-09-30	Free cash flow margin	Not reported	Revenue: 0 Open source
20142014-09-30	Free cash flow margin	Not reported	Revenue: 0 Open source
20152015-09-30	Free cash flow margin	Not reported	Revenue: 192000 Open source
20162016-09-30	Free cash flow margin	Not reported	Revenue: 100000 Open source Operating Cash Flow: -1730493 Open source
20212021-07-31	Free cash flow margin	-2,113.6%	Revenue: 64074 Open source Operating Cash Flow: -1320626 Open source Capital Expenditure: 33661 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -1.3M 2021

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20122012-09-30	Operating cash flow	Not reported	No source recorded
20132013-09-30	Operating cash flow	Not reported	No source recorded
20142014-09-30	Operating cash flow	Not reported	No source recorded
20152015-09-30	Operating cash flow	Not reported	No source recorded
20162016-09-30	Operating cash flow	-1730493	Operating Cash Flow: -1730493 Open source
20212021-07-31	Operating cash flow	-1320626	Operating Cash Flow: -1320626 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -1.4M 2021

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20122012-09-30	Free cash flow	Unavailable	No source recorded
20132013-09-30	Free cash flow	Unavailable	No source recorded
20142014-09-30	Free cash flow	Unavailable	No source recorded
20152015-09-30	Free cash flow	Unavailable	No source recorded
20162016-09-30	Free cash flow	Unavailable	Operating Cash Flow: -1730493 Open source
20212021-07-31	Free cash flow	-1354287	Operating Cash Flow: -1320626 Open source Capital Expenditure: 33661 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

74.8% 2021

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20122012-09-30	Liabilities / assets	1,011.9%	Total Liabilities: 1841238 Open source Total Assets: 181952 Open source
20132013-09-30	Liabilities / assets	670.9%	Total Liabilities: 1394849 Open source Total Assets: 207914 Open source
20142014-09-30	Liabilities / assets	4,668.5%	Total Liabilities: 1557269 Open source Total Assets: 33357 Open source
20152015-09-30	Liabilities / assets	690%	Total Liabilities: 1923150 Open source Total Assets: 278707 Open source
20162016-09-30	Liabilities / assets	749.7%	Total Liabilities: 2566986 Open source Total Assets: 342380 Open source
20212021-07-31	Liabilities / assets	74.8%	Total Liabilities: 4442457 Open source Total Assets: 5936056 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.19× 2021

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20122012-09-30	Current assets / current liabilities	0.05×	Current Assets: 90752 Open source Current Liabilities: 1841238 Open source
20132013-09-30	Current assets / current liabilities	0.09×	Current Assets: 131714 Open source Current Liabilities: 1394849 Open source
20142014-09-30	Current assets / current liabilities	0.02×	Current Assets: 26157 Open source Current Liabilities: 1557269 Open source
20152015-09-30	Current assets / current liabilities	0.06×	Current Assets: 114787 Open source Current Liabilities: 1923150 Open source
20162016-09-30	Current assets / current liabilities	0.09×	Current Assets: 225246 Open source Current Liabilities: 2459929 Open source
20212021-07-31	Current assets / current liabilities	0.19×	Current Assets: 845443 Open source Current Liabilities: 4338101 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2011 2010-10-01 – 2011-09-30	USD 40.86 million Exact value Exact value: 40861369 USD 2010-10-01 – 2011-09-30: 40861369 USD Inspect Net Income Open source Share or cite Citation for Net Income · Bio-Matrix Scientific Group, Inc. · 2011-09-30 Bio-Matrix Scientific Group, Inc. (edgar:1079282) Net Income: 40861369 USD Concept: fundies:NetIncome Period: 2010-10-01 to 2011-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1079282/explain?concept=fundies%3ANetIncome&period=2011-09-30&surface=latest&period_type=duration&start=2010-10-01&unit=USD&dimensions= Input fundies:NetIncome: 40861369 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1079282/000155479513000369/bmsn-20120930.xml#208623 Filing: 000155479513000369 The citation records this snapshot. The page link may show a newer release later.	−USD 869,118 Exact value Exact value: -869118 USD 2010-10-01 – 2011-09-30: -869118 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Bio-Matrix Scientific Group, Inc. · 2011-09-30 Bio-Matrix Scientific Group, Inc. (edgar:1079282) Operating Cash Flow: -869118 USD Concept: fundies:OperatingCashFlow Period: 2010-10-01 to 2011-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1079282/explain?concept=fundies%3AOperatingCashFlow&period=2011-09-30&surface=latest&period_type=duration&start=2010-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -869118 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1079282/000139390511000850/bmsn-20110930.xml#25062 Filing: 000139390511000850 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2012 2011-10-01 – 2012-09-30	−USD 1.75 million Exact value Exact value: -1752809 USD 2011-10-01 – 2012-09-30: -1752809 USD Inspect Net Income Open source Share or cite Citation for Net Income · Bio-Matrix Scientific Group, Inc. · 2012-09-30 Bio-Matrix Scientific Group, Inc. (edgar:1079282) Net Income: -1752809 USD Concept: fundies:NetIncome Period: 2011-10-01 to 2012-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1079282/explain?concept=fundies%3ANetIncome&period=2012-09-30&surface=latest&period_type=duration&start=2011-10-01&unit=USD&dimensions= Input fundies:NetIncome: -1752809 USD (2011-10-01 to 2012-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1079282/000155479514000005/bmsn-20130930.xml#228982 Filing: 000155479514000005 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2013 2012-10-01 – 2013-09-30	−USD 2 million Exact value Exact value: -2004997 USD 2012-10-01 – 2013-09-30: -2004997 USD Inspect Net Income Open source Share or cite Citation for Net Income · Bio-Matrix Scientific Group, Inc. · 2013-09-30 Bio-Matrix Scientific Group, Inc. (edgar:1079282) Net Income: -2004997 USD Concept: fundies:NetIncome Period: 2012-10-01 to 2013-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1079282/explain?concept=fundies%3ANetIncome&period=2013-09-30&surface=latest&period_type=duration&start=2012-10-01&unit=USD&dimensions= Input fundies:NetIncome: -2004997 USD (2012-10-01 to 2013-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1079282/000160706214000217/bmsn-20140930.xml#152132 Filing: 000160706214000217 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2014 2013-10-01 – 2014-09-30	−USD 2.08 million Exact value Exact value: -2080958 USD 2013-10-01 – 2014-09-30: -2080958 USD Inspect Net Income Open source Share or cite Citation for Net Income · Bio-Matrix Scientific Group, Inc. · 2014-09-30 Bio-Matrix Scientific Group, Inc. (edgar:1079282) Net Income: -2080958 USD Concept: fundies:NetIncome Period: 2013-10-01 to 2014-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1079282/explain?concept=fundies%3ANetIncome&period=2014-09-30&surface=latest&period_type=duration&start=2013-10-01&unit=USD&dimensions= Input fundies:NetIncome: -2080958 USD (2013-10-01 to 2014-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1079282/000160706216000817/bmsn-20150930.xml#378197 Filing: 000160706216000817 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2015 2014-10-01 – 2015-09-30	−USD 54.09 million Exact value Exact value: -54090319 USD 2014-10-01 – 2015-09-30: -54090319 USD Inspect Net Income Open source Share or cite Citation for Net Income · Bio-Matrix Scientific Group, Inc. · 2015-09-30 Bio-Matrix Scientific Group, Inc. (edgar:1079282) Net Income: -54090319 USD Concept: fundies:NetIncome Period: 2014-10-01 to 2015-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1079282/explain?concept=fundies%3ANetIncome&period=2015-09-30&surface=latest&period_type=duration&start=2014-10-01&unit=USD&dimensions= Input fundies:NetIncome: -54090319 USD (2014-10-01 to 2015-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1079282/000160706216000817/bmsn-20150930.xml#378069 Filing: 000160706216000817 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2016 2015-10-01 – 2016-09-30	Unavailable Not reported for this period.	−USD 1.73 million Exact value Exact value: -1730493 USD 2015-10-01 – 2016-09-30: -1730493 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Bio-Matrix Scientific Group, Inc. · 2016-09-30 Bio-Matrix Scientific Group, Inc. (edgar:1079282) Operating Cash Flow: -1730493 USD Concept: fundies:OperatingCashFlow Period: 2015-10-01 to 2016-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1079282/explain?concept=fundies%3AOperatingCashFlow&period=2016-09-30&surface=latest&period_type=duration&start=2015-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1730493 USD (2015-10-01 to 2016-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1079282/000160706216001102/bmsn-20160930.xml#455605 Filing: 000160706216001102 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2021 2020-08-01 – 2021-07-31	−USD 1.85 million Exact value Exact value: -1851108 USD 2020-08-01 – 2021-07-31: -1851108 USD Inspect Net Income Open source Share or cite Citation for Net Income · Bio-Matrix Scientific Group, Inc. · 2021-07-31 Bio-Matrix Scientific Group, Inc. (edgar:1079282) Net Income: -1851108 USD Concept: fundies:NetIncome Period: 2020-08-01 to 2021-07-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1079282/explain?concept=fundies%3ANetIncome&period=2021-07-31&surface=latest&period_type=duration&start=2020-08-01&unit=USD&dimensions= Input fundies:NetIncome: -1851108 USD (2020-08-01 to 2021-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1079282/000119983522000283/rivu-10k.htm#924219 Filing: 000119983522000283 The citation records this snapshot. The page link may show a newer release later.	−USD 1.32 million Exact value Exact value: -1320626 USD 2020-08-01 – 2021-07-31: -1320626 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Bio-Matrix Scientific Group, Inc. · 2021-07-31 Bio-Matrix Scientific Group, Inc. (edgar:1079282) Operating Cash Flow: -1320626 USD Concept: fundies:OperatingCashFlow Period: 2020-08-01 to 2021-07-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1079282/explain?concept=fundies%3AOperatingCashFlow&period=2021-07-31&surface=latest&period_type=duration&start=2020-08-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1320626 USD (2020-08-01 to 2021-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1079282/000119983522000283/rivu-10k.htm#942088 Filing: 000119983522000283 The citation records this snapshot. The page link may show a newer release later.	USD 33,661 Exact value Exact value: 33661 USD 2020-08-01 – 2021-07-31: 33661 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Bio-Matrix Scientific Group, Inc. · 2021-07-31 Bio-Matrix Scientific Group, Inc. (edgar:1079282) Capital Expenditure: 33661 USD Concept: fundies:CapitalExpenditure Period: 2020-08-01 to 2021-07-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1079282/explain?concept=fundies%3ACapitalExpenditure&period=2021-07-31&surface=latest&period_type=duration&start=2020-08-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 33661 USD (2020-08-01 to 2021-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1079282/000119983522000283/rivu-10k.htm#944284 Filing: 000119983522000283 The citation records this snapshot. The page link may show a newer release later.	−USD 1.35 million Calculation and evidence -1320626 − 33661 USD Exact free cash flow: -1354287 USD 2020-08-01 – 2021-07-31: -1320626 USD · Inspect Operating Cash Flow · Source 2020-08-01 – 2021-07-31: 33661 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Bio-Matrix Scientific Group, Inc. · 2021-07-31 Bio-Matrix Scientific Group, Inc. (edgar:1079282) Free cash flow: -1354287 USD Concept: free-cash-flow Period: 2020-08-01 to 2021-07-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1079282?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1320626 USD (2020-08-01 to 2021-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1079282/000119983522000283/rivu-10k.htm#942088 Filing: 000119983522000283 Input fundies:CapitalExpenditure: 33661 USD (2020-08-01 to 2021-07-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1079282/000119983522000283/rivu-10k.htm#944284 Filing: 000119983522000283 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

113 filings · 1,781 latest values · 1,781 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001079282, 1079282, edgar:1079282

Also known as Bio-Matrix Scientific Group, Inc., Rivulet Media, Inc., TASCO HOLDINGS INTERNATIONAL, INC., TASCO INTERNATIONAL INC

Bio-Matrix Scientific Group, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Net income

Operating cash flow

Company performance

What changed year over year

Where revenue goes

2021 2020-08-01 – 2021-07-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation